ProShare Advisors’s Constellation Pharmaceuticals, Inc. CNST Stock Holding History

ProShare Advisors’s Portfolio CNST Stock Details CNST Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q3	–	Sell	-18,021	Closed	-$609K	–	2392
2021 Q2	$609K	Buy	18,021 +3,197	+22%	+$81.5K	﹤0.01%	1384
2021 Q1	$347K	Buy	14,824 +677	+5%	+$20.5K	﹤0.01%	1704
2020 Q4	$407K	Buy	+14,147	New	+$356K	﹤0.01%	1400

ProShare Advisors's CNST Position: Q3 2021 in Review

ProShare Advisors sold out of Constellation Pharmaceuticals, Inc. (CNST) in Q3 2021, closing a stake of 18,021 shares — an estimated $609K sold.

ProShare Advisors first reported a position in CNST in Q4 2020 and held it in 3 quarters. The position peaked at $609K in Q2 2021. 0 funds tracked by Wall St. Rank hold CNST as of Q3 2021.

ProShare Advisors reported no remaining Constellation Pharmaceuticals, Inc. position as of Q3 2021 after selling out during the quarter.
ProShare Advisors sold 18,021 Constellation Pharmaceuticals, Inc. shares in Q3 2021, an estimated $609K.
ProShare Advisors first reported a position in Constellation Pharmaceuticals, Inc. in Q4 2020 and held it in 3 quarters.
ProShare Advisors's Constellation Pharmaceuticals, Inc. position peaked at $609K in Q2 2021.
0 funds tracked by Wall St. Rank held Constellation Pharmaceuticals, Inc. as of Q3 2021.

Based on ProShare Advisors's 13F filing for Q3 2021, filed 12 Nov 2021.